Hyperion DeFi Inc. (HYPD)
NASDAQ: HYPDHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
HYPD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $51.16M
- EPS (TTM)
- -$6.46
- Dividend yield
- None
- 52-week range
- 2.34 – 9.50
- Day range
- 3.27 – 3.49
- Volume / Avg
- 309.77K / 445.34K
- Beta
- —
- Shares outstanding
- 15.20M
52-week range
HYPD stock today
Hyperion DeFi (HYPD) closed at $3.37 on Oct 8, down 6.27% (-$0.225), versus the S&P 500's 0.47% decline. Shares are 64.6% below their 52-week high of $9.50, set on Oct 10, 2025 and 43.8% above the 52-week low of $2.34, near the bottom of the past year's range. HYPD is down 5.5% year to date, underperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has lost 62.9%.
Hyperion DeFi has posted a net loss over the last twelve months (EPS of -$6.46), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Hyperion DeFi
Company profileHyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Hyunsu Jung
- Headquarters
- Dallas, TX
- Employees
- 9
- IPO year
- 2018
- Website
- hyperiondefi.com
Analyst forecast
ForecastConsensus (2 analysts)
none
Avg. price target
$9.83+192.12%
- Strong buy 0
- Buy 2
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Hyperion DeFi peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SERSerina Therapeutics Inc. | 2.01 | 0.00% | $51.05M | vs HYPD |
| INMBINmune Bio Inc. | 1.83 | -1.61% | $50.79M | vs HYPD |
| CRBUCaribou Biosciences Inc. | 0.4812 | -22.06% | $51.59M | vs HYPD |
| ANVSAnnovis Bio Inc. | 1.17 | -3.31% | $49.93M | vs HYPD |
| CRVOCervoMed Inc. | 3.28 | +3.14% | $49.59M | vs HYPD |
| EDSAEdesa Biotech Inc. | 3.66 | -5.79% | $49.45M | vs HYPD |
| BSEMBioStem Technologies Inc. | 2.64 | +10.46% | $49.29M | vs HYPD |
| EXOZeXoZymes Inc. | 5.27 | -4.87% | $49.04M | vs HYPD |
Indexes, lists and sector
Appears in lists
Hyperion DeFi stock FAQ
What is Hyperion DeFi's stock price today?
HYPD last traded at $3.37 as of Oct 8, 4:00 PM EDT, down 6.27% on the day. Prices are delayed at least 15 minutes.
Does Hyperion DeFi pay a dividend?
No. Hyperion DeFi does not currently pay a regular cash dividend.
Who is Hyperion DeFi's CEO?
Mr. Hyunsu Jung is the chief executive officer of Hyperion DeFi Inc., which has about 9 employees.
Has HYPD ever split its stock?
Yes. The most recent HYPD stock split was a 1-for-80 split on Feb 3, 2025.
What is the HYPD 52-week high?
The 52-week high for HYPD is $9.50 and the 52-week low is $2.34. The stock is currently 64.6% below its high.